Collaborative partnerships to boost life-changing medical research
The Future Health Research and Innovation (FHRI) Fund has entered 4 new co-funding partnerships through the Co-Funding Partnerships Program (Co-FPP). The FHRI Fund will co-invest $5.75 million with this amount to be matched by partner organisations.
The Co-FPP was established to secure new funding for research and innovation in Western Australia. The Co-FPP enables partnerships to be established to develop new funding programs or maximise the impact of existing funding programs that are aligned with the FHRI Fund Priority Goals and to build a culture that supports co-operation and interconnectedness.
The FHRI Fund will partner with the Cancer Council WA to support, develop, and retain cancer research capacity and leadership in WA, and improve WA researchers’ competitiveness for national funding.
The FHRI Fund will partner with Cystic Fibrosis Western Australia to provide grant opportunities that will attract and retain early to mid-career researchers in Cystic Fibrosis fields.
The FHRI Fund will partner with The Hospital Research Foundation Group to support fellowships in preventative health across priority populations in WA and provide grants into personalised treatment programs focused on cancer, neurodegenerative and cardiovascular disease.
Further information will be made available when the co-funded partnership programs open for applications.
The Co-FPP recipients are shown below:
| Partner organisation | Funding program title | FHRI Fund co-contribution |
| Cancer Council WA | Strategic Priority Program – Capacity Building | $6,000,000 |
| Cystic Fibrosis WA | WA Cystic Fibrosis Research Collaborative Program | $2,000,000 |
| The Hospital Research Foundation Group | Early & Mid-Career Research Fellowships in Preventative Health for Priority Populations | $2,000,000 |
| The Hospital Research Foundation Group | Innovations in Personalised Medicine | $1,500,000 |